Sanofi SA - Other Operating Expenses

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Other-Operating-Expenses" stands at 6.22 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.

Sanofi SA's third quarter result of 2.01 Billion EUR for the item "Other Operating Expenses" represents an increase of 679.25 percent compared to it's second quarter result.

Also, Sanofi SA's third quarter result of 2.01 Billion EUR for the item "Other Operating Expenses" represents an increase of 5.57 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 6.22 Billion EUR for the item "Other Operating Expenses" represents an increase of 1.73 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.44 Billion Euros compared to the value the year prior.
The 1 year change is 3.44 Billion Euros.
The 3 year change is 0.155 Billion Euros.
The 5 year change is 7.23 Billion Euros.
The 10 year change is 5.69 Billion Euros.

The Serie's long term average value is 2.75 Billion Euros. It's latest available value, on 09/30/2025, is 3.48 Billion Euros higher, compared to it's long term average value.
The Serie's change in Euros from it's minimum value, on 06/30/2020, to it's latest available value, on 09/30/2025, is +9.11 Billion.
The Serie's change in Euros from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -1.41 Billion.